TELA Bio, Inc. — Form 10-Q
Filed August 11, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
CEO Heather Getz and CFO/COO Roberto Cuca signed routine SOX 302 and 906 certifications on August 11, 2026, affirming the Q2 2026 10-Q filing fairly presents financial condition and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or fraud were disclosed.
Why this rating
Boilerplate SOX certification exhibit; standard periodic disclosure with no substantive business developments disclosed.
See more from August 11, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.